Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cyrano Therapeutics logo — Sense the world around you. Leading the way in Smell and Fla...

Cyrano Therapeutics

Sense the world around you. Leading the way in Smell and Flavor Restoration

Founded 2014 United States Delray Beach, United States 6 employees Series B Total: $21.80M Health Care, Health and Wellness +1

General Information

Company Name Cyrano Therapeutics
Founded Year 2014
Location United States Delray Beach, United States
Employees 6
Industries Health Care, Health and Wellness, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Cyrano Therapeutics. To contact Cyrano Therapeutics, visit cyranotherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cyrano Therapeutics compare?

A PDF of Cyrano Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cyrano Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cyrano Therapeutics

Cyrano Therapeutics is a health care startup leading the way in smell and flavor restoration, aiming to address the significant impact of chronic loss of taste and smell on the safety, quality of life, and well-being of more than 40 million people in the US and Europe, and millions more worldwide. The company's unique intranasal formulation, CYR-064, has shown promising results in a 92-patient pilot study. Currently, Cyrano is conducting a Phase 2 placebo-controlled double-blind randomized trial at 14 sites in the United States, with data readout expected in Q1'25. Founded in 2014 and headquartered in the United States, Cyrano Therapeutics recently secured a $9.00M Series B investment on 16 January 2024, with participation from Deepwork Capital, Lumira Ventures, and Remiges Ventures. The company's innovative approach to addressing a prevalent and underserved medical condition, combined with successful clinical results and a strong investor backing, positions Cyrano as a noteworthy player in the health care industry. For more information, visit their website at www.cyranotherapeutics.com.

Business keywords: biopharmaceutical, intranasal formulation, taste and smell restoration, chronic condition, patient study, Phase 2 trial, proprietary formulation, clinical research

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $9.00M 4
Deepwork Capital Lumira Ventures Remiges Ventures
Deepwork Capital, Lumira Ventures +2
16 Jan 2024
Series B Undisclosed 1
Florida Opportunity Fund
Florida Opportunity Fund
22 Dec 2023
Series A $12.80M 2
Lumira Ventures Remiges Ventures
Lumira Ventures, Remiges Ventures
10 Dec 2020

Cyrano Therapeutics Alternatives & Competitors

View All Alternatives
Cyrano Therapeutics vs
Cara Therapeutics
Cara Therapeutics United States

Transforming the way pruritus is treated to bring quality to the lives of those who suffer

Post-IPO Debt
46 employees
Biotechnology, Health Care
Cyrano Therapeutics vs
Milestone Pharmaceuticals, Inc.
Milestone Pharmaceuticals, Inc. Canada

Headquartered in Montreal, with a growing subsidiary in Charlotte, NC

IPO
126 employees
Biotechnology, Health Care
Cyrano Therapeutics vs
Wilson Therapeutics
Wilson Therapeutics

Innovative pathways to treat rare conditions and enhance patient lives

Post-IPO Equity
Biotechnology, Health Care
View all alternatives

FAQ About Cyrano Therapeutics

Sense the world around you. Leading the way in Smell and Flavor Restoration
Cyrano Therapeutics was founded in 2014.
Cyrano Therapeutics is headquartered in Delray Beach, United States.
Cyrano Therapeutics operates in Health Care, Health and Wellness and Medical Devices. Its work centres on biopharmaceutical, intranasal formulation, taste and smell restoration and chronic condition.
Cyrano Therapeutics has approximately 6 employees.
Cyrano Therapeutics has completed 3 funding rounds, raising a total of $21.80M. The latest funding stage is Series B.
Top alternatives and competitors to Cyrano Therapeutics include Cara Therapeutics, Milestone Pharmaceuticals, Inc., Wilson Therapeutics, Renibus Therapeutics Inc, Cirius Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cyrano Therapeutics and Cara Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cyrano Therapeutics, https://bouncewatch.com/company/cyrano-therapeutics, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout